Spinal Anesthesia Magnesium Infusion
Completed
- Conditions
- Operation
- Registration Number
- NCT02011152
- Lead Sponsor
- Karadeniz Technical University
- Brief Summary
The aim of this study was to investigate the effect of i.v. infusion of magnesium sulphate during spinal anesthesia on duration of spinal block and postoperative pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- ASA physical status I and II, aged between 18 and 65 female patients undergoing abdominal hysterectomy
Exclusion Criteria
- severe cardiovascular, renal and hepatic dysfunction, neuromuscular diseases, using calcium channel blockers, and inappropriate for spinal anesthesia.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain scores 6 mo
- Secondary Outcome Measures
Name Time Method sensory block 6 mo
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain magnesium sulfate's effect on spinal anesthesia in abdominal hysterectomy?
How does intravenous magnesium sulfate compare to standard-of-care analgesics in postoperative pain management for abdominal hysterectomy?
Are there specific biomarkers that predict enhanced sensory block duration with magnesium sulfate infusion during spinal anesthesia?
What are the potential adverse events associated with magnesium sulfate infusion during spinal anesthesia and how are they managed?
What combination therapies or alternative agents show synergistic effects with magnesium sulfate in improving postoperative outcomes in abdominal hysterectomy?